| Martin's physical pharmacy and pharmaceutical sciences PJ Sinko New Jersey: Department of Pharmaceutics Ernest Mario School of Pharmacy …, 2006 | 1391* | 2006 |
| Tumor-specific targeting of an anticancer drug delivery system by LHRH peptide SS Dharap, Y Wang, P Chandna, JJ Khandare, B Qiu, S Gunaseelan, ... Proceedings of the National Academy of Sciences 102 (36), 12962-12967, 2005 | 488 | 2005 |
| Estimating human oral fraction dose absorbed: a correlation using rat intestinal membrane permeability for passive and carrier-mediated compounds GL Amidon, PJ Sinko, D Fleisher Pharmaceutical research 5, 651-654, 1988 | 388 | 1988 |
| Recent trends in targeted anticancer prodrug and conjugate design Y Singh, M Palombo, PJ Sinko Current medicinal chemistry 15 (18), 1802-1826, 2008 | 365 | 2008 |
| The effect of physical barriers and properties on the oral absorption of particulates DA Norris, N Puri, PJ Sinko Advanced drug delivery reviews 34 (2-3), 135-154, 1998 | 334 | 1998 |
| Direct evidence for peptide transporter (PepT1)-mediated uptake of a nonpeptide prodrug, valacyclovir PV Balimane, I Tamai, A Guo, T Nakanishi, H Kitada, FH Leibach, A Tsuji, ... Biochemical and biophysical research communications 250 (2), 246-251, 1998 | 302 | 1998 |
| Characterization of the regional intestinal kinetics of drug efflux in rat and human intestine and in Caco-2 cells VD Makhey, A Guo, DA Norris, P Hu, J Yan, PJ Sinko Pharmaceutical research 15, 1160-1167, 1998 | 290 | 1998 |
| Mechanisms mediating the vesicant actions of sulfur mustard after cutaneous exposure MP Shakarjian, DE Heck, JP Gray, PJ Sinko, MK Gordon, RP Casillas, ... Toxicological sciences 114 (1), 5-19, 2010 | 240 | 2010 |
| Molecular targeting of drug delivery systems to ovarian cancer by BH3 and LHRH peptides SS Dharap, B Qiu, GC Williams, P Sinko, S Stein, T Minko Journal of controlled release 91 (1-2), 61-73, 2003 | 233 | 2003 |
| Effect of size, surface charge, and hydrophobicity on the translocation of polystyrene microspheres through gastrointestinal mucin DA Norris, PJ Sinko Journal of applied polymer science 63 (11), 1481-1492, 1997 | 233 | 1997 |
| Predicting fraction dose absorbed in humans using a macroscopic mass balance approach PJ Sinko, GD Leesman, GL Amidon Pharmaceutical research 8, 979-988, 1991 | 225 | 1991 |
| Involvement of multidrug resistance-associated proteins in regulating cellular levels of (−)-epigallocatechin-3-gallate and its methyl metabolites J Hong, JD Lambert, SH Lee, PJ Sinko, CS Yang Biochemical and biophysical research communications 310 (1), 222-227, 2003 | 216 | 2003 |
| Physiologically-based pharmacokinetic simulation modelling GM Grass, PJ Sinko Advanced Drug Delivery Reviews 54 (3), 433-451, 2002 | 191 | 2002 |
| Evidence for diminished functional expression of intestinal transporters in Caco-2 cell monolayers at high passages H Yu, TJ Cook, PJ Sinko Pharmaceutical research 14, 757-762, 1997 | 173 | 1997 |
| Oral absorption of the HIV protease inhibitors: a current update GC Williams, PJ Sinko Advanced drug delivery reviews 39 (1-3), 211-238, 1999 | 172 | 1999 |
| A hydrogel prepared by in situ cross-linking of a thiol-containing poly (ethylene glycol)-based copolymer: a new biomaterial for protein drug delivery B Qiu, S Stefanos, J Ma, A Lalloo, BA Perry, MJ Leibowitz, PJ Sinko, ... Biomaterials 24 (1), 11-18, 2003 | 171 | 2003 |
| Interactions of a nonpeptidic drug, valacyclovir, with the human intestinal peptide transporter (hPEPT1) expressed in a mammalian cell line A Guo, P Hu, PV Balimane, FH Leibach, PJ Sinko Journal of Pharmacology and Experimental Therapeutics 289 (1), 448-454, 1999 | 167 | 1999 |
| Oxidants and antioxidants in sulfur mustard–induced injury JD Laskin, AT Black, YH Jan, PJ Sinko, ND Heindel, V Sunil, DE Heck, ... Annals of the New York Academy of Sciences 1203 (1), 92-100, 2010 | 163 | 2010 |
| Surface modifications of nanocarriers for effective intracellular delivery of anti-HIV drugs S Gunaseelan, K Gunaseelan, M Deshmukh, X Zhang, PJ Sinko Advanced drug delivery reviews 62 (4-5), 518-531, 2010 | 162 | 2010 |
| Enhancing the anticancer efficacy of camptothecin using biotinylated poly (ethyleneglycol) conjugates in sensitive and multidrug-resistant human ovarian carcinoma cells T Minko, PV Paranjpe, B Qiu, A Lalloo, R Won, S Stein, PJ Sinko Cancer chemotherapy and pharmacology 50, 143-150, 2002 | 162 | 2002 |
Debra LaskinRutgers University在 eohsi.rutgers.edu 的电子邮件经过验证
